+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 6Years +
All Genders
Healthy Volunteers
ID07201025

Study of New MRI Techniques to Measure Kidney Disease Progression in ARPKD Patients and Healthy Controls Ages 6 and Older

Led by The Cleveland Clinic · Updated on 2025-11-21

60

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Autosomal Recessive Polycystic Kidney Disease ARPKD is a serious genetic condition affecting children, with no current specific treatments and significant risks including kidney failure by age 18. This prospective, observational study aims to develop new MRI-based measures that can quickly and reliably track kidney disease progression in ARPKD patients aged 6 and older. These biomarkers could improve how responses to future therapies are measured across different stages of the disease and ages. The study will enroll 45 ARPKD patients divided into three groups based on kidney function early, mild, and moderate chronic kidney disease and 15 healthy controls. ARPKD participants will have four annual visits over three years, including MRI scans, clinical data collection, blood and urine tests, and a special kidney function test called iohexol clearance. Healthy controls will have one study visit with similar assessments except for the kidney function test. The MRI scans use advanced techniques to evaluate kidney structure and function without contrast. Participants will provide clinical and demographic information, undergo blood and urine testing, and have multiple MRI scans to measure kidney health over time. Researchers will assess how well the new MRI biomarkers detect disease stage and progression compared to standard kidney function tests. The study also explores a new MRI method that may allow scanning young children without sedation. Safety and test repeatability will be monitored at two research sites, with the study lasting up to five years in total.

CONDITIONS

Brief Title

Imaging Assessments of ARPKD Kidney Disease Progression

Research Team

K

Katherine M Dell, MD

R

Research Coordinator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here